Figures & data
Table 1 Baseline demographics and clinical characteristics of patients in the training cohort and the validation cohort
Table 2 Univariate analysis of the training cohort
Table 3 Multivariate analysis of the training cohort
Figure 1 Nomogram for predicting overall survival after curative resection of PHCC.
Notes: To obtain the corresponding survival probability, sum up each variable score and draw a vertical line from the total points scale to the survival rate scale.
Abbreviations: ALB, albumin; PHCC, primary hepatocellular carcinoma; PVTT, portal vein tumor thrombus; TBil, total bilirubin.
![Figure 1 Nomogram for predicting overall survival after curative resection of PHCC.Notes: To obtain the corresponding survival probability, sum up each variable score and draw a vertical line from the total points scale to the survival rate scale.Abbreviations: ALB, albumin; PHCC, primary hepatocellular carcinoma; PVTT, portal vein tumor thrombus; TBil, total bilirubin.](/cms/asset/bba7b86b-0248-4b7f-9124-80986f541c60/dcmr_a_12186235_f0001_b.jpg)
Figure 2 Calibration curves for predicting overall survival probability by the nomogram in the training and validation sets.
Notes: Calibration curves of the prognostic nomogram for 1-year overall survival (A), 3-year overall survival (B) and 5-year overall survival (C) in the training set, correspondingly, calibration curves for 1-year overall survival (D), 3-year overall survival (E), and 5-year overall survival (F) in the validation set.
![Figure 2 Calibration curves for predicting overall survival probability by the nomogram in the training and validation sets.Notes: Calibration curves of the prognostic nomogram for 1-year overall survival (A), 3-year overall survival (B) and 5-year overall survival (C) in the training set, correspondingly, calibration curves for 1-year overall survival (D), 3-year overall survival (E), and 5-year overall survival (F) in the validation set.](/cms/asset/1808fa11-2bbc-4b61-b01d-19f9113fcc71/dcmr_a_12186235_f0002_c.jpg)
Figure 3 The tdROC curve of the prognostic nomogram, S-index, CLIP, BCLC and Okuda score in the training cohort.
Note: The tdROC curve for 1-year survival (A), 3-year survival (B), and 5-year survival (C).
Abbreviations: BCLC, Barcelona Clinic Liver Cancer; CLIP, Cancer of the Liver Italian Program; tdROC, time-dependent receiver operating characteristic.
![Figure 3 The tdROC curve of the prognostic nomogram, S-index, CLIP, BCLC and Okuda score in the training cohort.Note: The tdROC curve for 1-year survival (A), 3-year survival (B), and 5-year survival (C).Abbreviations: BCLC, Barcelona Clinic Liver Cancer; CLIP, Cancer of the Liver Italian Program; tdROC, time-dependent receiver operating characteristic.](/cms/asset/eb53d16e-c9e8-483e-9ffe-f4da80e0064f/dcmr_a_12186235_f0003_c.jpg)
Figure 4 Survival curves stratified by the score calculated by the nomogram in the training cohort (low risk: <200; intermediate risk: 200–250; and high risk: >250).
![Figure 4 Survival curves stratified by the score calculated by the nomogram in the training cohort (low risk: <200; intermediate risk: 200–250; and high risk: >250).](/cms/asset/b83a5e43-fd39-4ff8-bf4a-efdc4f9eeaaa/dcmr_a_12186235_f0004_c.jpg)
Table 4 Nomogram scoring system
Table S1 The optimal cutoff value of S-index